Why does clinical AI need independent release review?
Clinical AI needs independent release review because a model's self-check can repeat its own assumptions and blind spots. Self-checking may flag omissions or contradictions, but release still requires source-data checks, explicit criteria, and a decision by an authorized human reviewer.
A model's self-check can catch obvious omissions, formatting errors, or contradictions, so it can contribute to quality control. It is not independent evidence. When the same model generates a clinical conclusion and then evaluates it, the evaluation can repeat the same missing context, assumptions, or interpretation errors. A high self-score therefore does not establish that the output is ready for release.
Independent release review separates drafting from acceptance. The workflow can apply testable rules, compare the draft with source data, use a separate evaluation where appropriate, preserve the evidence reviewed, and route the result to an authorized clinician. That reviewer must be able to inspect, edit, reject, and document the decision. Micromeet Care Workspace can coordinate configured review stages and audit evidence, while each institution defines its roles and release criteria. AI writes. Doctors decide.
Related questions
Can AI self-review still be useful?+
What makes a clinical AI review independent?+
Micromeet builds governed healthcare AI infrastructure for continuous care. MCU CoPilot, AI Scribe, AI Front Desk and Care Loop support focused workflows; Micromeet Care Workspace carries approved context and next steps between them. Clinicians and authorized staff review consequential outputs. See the public benchmark →